J&J Sues in Bid to Halt Medicare Drug Price Negotiations

Johnson & Johnson sued the US government on Tuesday, becoming the latest drugmaker seeking to block a program that gives the Medicare government health insurance plan the power to negotiate lower drug prices.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/994493?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost